Stollman is chief of the Division of Gastroenterology at the Alta Bates Summit Medical Center and works at the East Bay Center for Digestive Health, both in Oakland, California.. Twenty years ago, a ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...

Fecal microbiota transplant has been used as the traditional treatment for C. diff. infection for a little over a decade. The procedure, which is done via colonoscopy, involves transplanting a small ...

A fecal transplant performs as well as antibiotics in treating people with a bacterial infection that can cause life-threatening diarrhea, a new study says. People who received a single fecal ...

A fecal microbiota transplant (FMT) not only cured a case of Clostridium difficile (C. diff) infection in a 66 year old man; it eliminated populations of multi-drug resistant organisms both in the ...

A fecal transplant, as it's often called, is exactly what it sounds like. One person's, um, poop is put into another person's body. It works, scientists theorize, by re-introducing good microbes into ...

Fecal microbiota transplantation (FMT), shown to be effective in the treatment of recurrent Clostridioides difficile infection (CDI), also shows significant benefit in the treatment of primary CDI, ...

Microbiota restoration may be a solution for effectively treating patients with Clostridiodes difficile infection, according to researchers. The primary outcome of this study found a 90% resolution of ...

The US Food and Drug Administration (FDA) on Monday announced new draft guidance that aims to further assure that patients infected with the bacterium Clostridium difficile and not responding to ...

HealthDay News — The vast majority of patients with recurrent Clostridium difficile infection (CDI) recovered after receiving fecal transplantation via colonoscopy, study findings indicate. Among ...

Chronic infections with C. diff have reignited interest in fecal transplantation, a procedure that is still not covered by health insurance, according to a report by ABC News. Patients with ...

With an FDA approval to treat Clostridium difficile with a fecal microbiome therapy, Switzerland-based Ferring Pharmaceuticals has beat out Seres Therapeutics, which is due for an FDA decision in ...